Human derived dimerization tag enhances tumor killing potency of a T-cell engaging bispecific antibody.
about
Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumorsChimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology.Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody.Progress and opportunities for immune therapeutics in osteosarcoma.The making of bispecific antibodiesT cell engaging bispecific antibody (T-BsAb): From technology to therapeutics.TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.
P2860
Q37078941-B73522AA-3B6D-4177-A28D-2A4004AB81D2Q38400420-6A114E7B-520A-4D35-A581-FA1DCBC1CE3AQ38707896-D09C49C7-D0DF-42A8-92F5-FFB6A0A9D39FQ38948905-FED91F69-F76E-4646-8A11-4C50BEB58A00Q42323236-CB87FAA0-B065-43AE-838F-7AE18102DE74Q47570404-519AF89F-259E-4080-9700-C7A3E4D766BFQ52691571-891464E9-951A-490F-9789-2E55A5AEB642
P2860
Human derived dimerization tag enhances tumor killing potency of a T-cell engaging bispecific antibody.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Human derived dimerization tag ...... engaging bispecific antibody.
@en
type
label
Human derived dimerization tag ...... engaging bispecific antibody.
@en
prefLabel
Human derived dimerization tag ...... engaging bispecific antibody.
@en
P2093
P2860
P1433
P1476
Human derived dimerization tag ...... engaging bispecific antibody.
@en
P2093
Irene Y Cheung
Mahiuddin Ahmed
Ming Cheng
N K Cheung
P2860
P304
P356
10.4161/2162402X.2014.989776
P577
2015-04-27T00:00:00Z